Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Description

Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.

Conditions

HIV/AIDS

Study Overview

Study Details

Study overview

Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Condition
HIV/AIDS
Intervention / Treatment

-

Contacts and Locations

Hobson City

Health Services Center, Inc., Hobson City, Alabama, United States, 36202

Opelika

Unity Wellness Center, Opelika, Alabama, United States, 36801

New Orleans

Louisiana State University Health Sciences Center in New Orleans, New Orleans, Louisiana, United States, 70112

Jackson

University of Mississippi Medical Center, Jackson, Mississippi, United States, 39216

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Be able to speak, read, and write in English;
  • * Be above 18 years of age;
  • * Be willing to participate in any assigned arm of the intervention;
  • * Have an HIV-1 RNA level \>200 copies/mL;
  • * Own a smartphone;
  • * Be able and willing to provide informed consent for study participation and consent for access to medical records.
  • * Live, work and or receive care in AL, LA, or MS
  • * Have been diagnosed with HIV ≤3 months ago;
  • * Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment;
  • * Terminal illness with life expectancy \<6 months; and
  • * Planning to move out of the area in the next 12 months.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Columbia University,

Rebecca Schnall, PhD, MPH, PRINCIPAL_INVESTIGATOR, Columbia University

Scott Batey, PhD, MSW, PRINCIPAL_INVESTIGATOR, Tulane University

Study Record Dates

2027-12-22